A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Oritavancin | CAS 171099-57-3 - Request Quote

Picture of Oritavancin
SZ CAT No:SZ-O026001
CAS No
171099-57-3
Mol.F.
C86H97Cl3N10O26
Mol.Wt.
1793.1
Inv. Status
Synthesis on demand
Rel. CAS No192564-14-0 (diphosphate salt)
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Oritavancin is chemically Vancomycin, 22-​O-​(3-​amino-​2,​3,​6-​trideoxy-​3-​C-​methyl-​α-​L-​arabino-​hexopyranosyl)​-​N3''-​[(4'-​chloro[1,​1'-​biphenyl]​-​4-​yl)​methyl]​-​, (4''R)​-​,. Oritavancin is supplied with detailed characterization data compliant with regulatory guideline. Oritavancin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Oritavancin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 171099-57-3

Purchase 171099-57-3

Order 171099-57-3

Enquire 171099-57-3

price of 171099-57-3

171099-57-3 Supplier

171099-57-3 Manufacturer

171099-57-3 Exporter

buy high quality Oritavancin

Purchase Oritavancin

Oritavancin suppliers

Oritavancin manufacturers

Oritavancin price

Order Oritavancin

Enquire Oritavancin

Oritavancin cost

Oritavancin Supplier

Oritavancin Distributor

Oritavancin for Method Validation

Oritavancin Reference Standard

Oritavancin for ANDA Filing

Oritavancin for Forced Degradation Studies

Oritavancin Identification Standards

Oritavancin for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,